Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    According to the Graphical Research new growth forecast report titled “APAC Dermal Filler Market Size By Type (Biodegradable {Temporary Biodegradable, Semi-permanent Biodegradable}, Non-biodegradable), By Material Type (Hyaluronic Acid {HA}, Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-Methacrylate Microspheres {PMMA}, Fat), By Application (Facial Line Correction, Face Lift, Lip Enhancement), By End-use (Dermatology Clinics, Hospitals), Industry Analysis Report, Regional Outlook (China, India, Japan, Australia, South Korea, Singapore, Malaysia, Thailand, Taiwan, Philippines)”, Estimated To Exceed USD 2.0 Billion By 2026.

    Growing spending on aesthetic treatment with increasing out-of-pocket expenditure in developing Asian countries will spur the regional market growth. Increasing purchasing capacity of the population to spend on premium cosmetic surgeries to enhance facial appearance will drive the adoption of dermal fillers, thereby influencing the product demand. Rising medical tourism further stimulates the industry growth potential. For instance, according to Ministry of Health and Welfare, about 48,849 foreign patients visited South Korea for cosmetic treatments with over USD 180 million spending. Thus, considering increasing spending and awareness, the industry will foresee significant growth opportunities in the foreseeable future.  

    Huge demand for minimally invasive treatments will positively impact the APAC dermal filler market size in coming years. According to the International Society of Aesthetic Plastic Surgery, in Australia, about 100,238 non-surgical aesthetic procedures were performed in 2018. Additionally, during the same period nearly 35,000 non-invasive procedures were reported in Thailand. With developing technologies and acceptance of advanced treatments among the population, the demand for dermal fillers will grow robustly over the forecast timeframe. However, risk associated with post procedural complications can limit the product adoption upto some extent.

    Non-biodegradable dermal filler market held over USD 150 million revenue in 2019. Long-lasting effects associated with non-biodegradable dermal fillers provide growth opportunities to the segment. These fillers offer convenience as it reduces the frequent injections or treatment. The applications of permanent fillers in the treatment of nasolabial folds will further impel the product adoption among healthcare professionals as well as patients in the coming years.

    Calcium hydroxylapatite (CaHA) dermal filler segment is forecasted to foresee 8.1% CAGR over projection period. Benefits of CaHA dermal filler to enhance the appearance of moderate to severe facial folds and wrinkles will contribute to the segment growth. several firms are developing CaHA-based dermal filler products. Moreover, with growing geriatric population in Japan, China and India along with other countries, the segment will witness considerable growth in the forthcoming years.

    Face lift application segment held around 20% revenue share in 2019. Face lift is among the most popular cosmetic treatment in female population across the world. For instance, in Japan, about 27,210 face lift treatments were reported. Also, in India, nearly 7,900 and in Australia over 3,301 face lift procedures were performed in 2018. Additionally, preference for non-surgical and minimally invasive alternatives influences the demand for liquid face lift using soft tissue fillers. Development in face lift procedures leading to minimal side effect and faster rejuvenation will further contribute to the consumer preference.

    On the basis of end-use, APAC dermal filler market is segmented as dermatology clinics, hospitals and others. Hospitals segment is forecasted to witness 7.2% CAGR during the forecast timeframe. The segment growth is primarily attributable to the growing healthcare infrastructure and highly skilled staff. Additionally, increasing visits of medical tourists in leading hospitals to access cosmetic treatments will further boost the growth potential in the projection period.

    Japan dermal filler market held significant market share and is projected to proceed at 7.8% CAGR till 2026. Rising adoption of aesthetic procedures for youthful appeal will propel the market growth in the country. Substantial amount of elderly population that creates demand for facial lines treatment with high spending ability will positively impact the market revenue. Furthermore, increasing development and launch of developed dermal filler products by regional companies will aid in market expansion over the coming years.

    Renowned players in APAC dermal filler market are AbbVie Inc, (Allergan Plc.), Merz Aesthetics, Galderma, 9.6.      Huons Global Co., Ltd.  and Teoxane Laboratories among others. These market players are formulating various strategies such as agreements, acquisitions and geographic expansion to broaden their market foothold in the region. For instance, in April 2019, Merz pharma announced the launch of Belotero Revive, a combination of hyaluronic acid and glycerol specifically designed to enhance elasticity, hydration and firmness of the skin. The product launch was aimed at expanding the firm’s reach and product sales.

    APAC dermal filler market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:

    APAC Dermal Filler Market, By Type, 2015-2026 (USD Million)

    • Biodegradable
      • Temporary biodegradable
      • Semi-permanent biodegradable
    • Non-biodegradable

    APAC Market, By Material Type, 2015 – 2026 (USD Million)

    • Hyaluronic Acid (HA)
    • Calcium Hydroxylapatite
    • Poly-L-lactic Acid
    • Polymethyl-methacrylate Microspheres (PMMA)
    • Fat
    • Others

    Market, By Application, 2015 – 2026 (USD Million)

    • Facial Line Correction
    • Face Lift
    • Lip Enhancement
    • Others

    APAC Dermal Filler Market, By End-use, 2015-2026 (USD Million)

    • Dermatology Clinics
    • Hospitals
    • Others

    The above information is provided for the following region and countries:

    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Singapore
      • Malaysia
      • Thailand
      • Taiwan
      • Philippines
      • Others

    LSI keywords:

    • Asia Pacific Facial Filler Market
    • Asia Pacific Soft Tissue Fillers Market
    • Asia Pacific Facial Injectables Market